TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 10 | 31 | 25 | 16 | -10 | 16 | 15 |
| P | %wins | 67 | 100 | 100 | 67 | 33 | 67 | 72 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/21/16 14:43 | 1/19/16 | CASI | Casi Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hu Cynthia W. | MD | O | COO | P | 12 | 0.7209 | 0 | 17 | 22 | 93 | D | -63 | -54 | -55 | -49 | -27 | -26 | -18 | -5 | -4 | 53 | 20 | 74 | 42 | 65 |
5/3/12 20:45 | 5/1/12 | ENMD | Entremed Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hu Cynthia W. | MD | O | COO,GC,S | P.d | 0 | 0.00 | 0 | 75 | 999% | 76 | I | ||||||||||||||
9/17/08 14:00 | 9/17/08 | ENMD | Entremed Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wong Cynthia | MD | O | VP,GC,Se | P | 1 | 0.4000 | 0 | 3 | 30 | 11 | D | -83 | -72 | -44 | -40 | -45 | -33 | -30 | -21 | 18 | 18 | 15 | -27 | -39 | 52 |
3/20/08 07:28 | 3/19/08 | ENMD | Entremed Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wong Cynthia | MD | O | VP,GC,Se | P | 5 | 0.5894 | 0 | 8 | New | 8 | D | -77 | -62 | -51 | -58 | -47 | -38 | -34 | -12 | 16 | 21 | 41 | 2 | -33 | -69 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |